Skip to main content
SpringerLink
Log in

Present status of study on reversion of anti-leukemic multidrug resistance

  • Review
  • Published:
Chinese Journal of Integrated Traditional and Western Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. meng HT, lin XJ, lin MF. Experimental study on effect of CsA in reversing multidrug resistance of the sensitivity of acute leukemic cell. Chin J Hematol 1996; 17 (6): 319–320.

    Google Scholar 

  2. meng HT, lin XJ, lin MF. Influence of CsA on drug accumulation and excretion in K562/DOX cells. Chin J Hematol 1997; 18(5): 254–256.

    CAS  Google Scholar 

  3. tang JM, huang RW, li MQ, et al. Effect of CsA on Vm26 in enhancing the apoptosis induction in HL-60 cells. Chin J Hematol 1999;20(l):44–45.

    Google Scholar 

  4. zhao CT, bian SG, yang CZ, et al. A case of acute myelocytic leukemia with multidrug resistance reversed by CsA. Chin J Hematol 1995; 16(8): 347–349.

    Google Scholar 

  5. li XM, wu JX, zhang LS, et al. Clinical study on multidrug resistance reversion of CsA in recurrent intractable leukemia. Chin J Hematol 1997;18(2): 73–75.

    Google Scholar 

  6. liu LH, liu FQ, yang CZ, et al. Study on multidrug resistance reversion of IL-2 and IFN-α in leukemic cells. Chin J Hematol 1997;18(12): 646–648.

    CAS  Google Scholar 

  7. an JF, chen JM, li XZ, et al. Regulatory effect of G- CSF on P-gp expression in acute myelocytic leukemia. Chin J Hematol 1998; 19(2): 98–99.

    Google Scholar 

  8. an JF, chen JM, li XZ, et al. Regulatory effect of G- CSF on primary mdr-1/P-gp expression in acute myelocytic leukemic cell. Chin J Hematol 1998; 19(7): 342–345.

    CAS  Google Scholar 

  9. wang JC, wang QY, chen XH, et al. Study on effect of rhIL-3 in enhancing the sensitivity of acute myelocytic leukemic cells to rubidomycin. Chin J Hematol 1999;20(1): 30–32.

    Google Scholar 

  10. zhang XH, ge XY, wang C, et al. Influences of IL-3, G-CSF and GM-CSF on toxicity of Ara-C cells. Leukemia 1999;8(2): 97–98.

    Google Scholar 

  11. zhang XZ, chen YX, wang XH, et al. Experimental study on effect of umbilic blood plasma in enhancing anti-leukemic effect of Ara-C. Chin J Hematol 1999; 20(5): 229–231.

    Google Scholar 

  12. fu JR, li CR, yang XQ, et al. Study on multidrug resistance reversion of recombined human interleukin 4 in HL-60/VCR cells. Chin J Hematol 2000; 21 (2): 94–95.

    Google Scholar 

  13. hu B, zuo DP, yang CZ. Progress of study on applying antisense technique in reversing drug resistance of tumor. Chin J Hematol 1997;18(2): 106–108.

    Google Scholar 

  14. cao J, hu X, pan JR, et al. Construction of MDRl antisense RNA expression plasmid and its application in studying mechanism of anti-multidrug resistance. Chin J Med 1995;75(10): 557–558.

    Google Scholar 

  15. li HF, sun GX, lu WW, et al. Primary study on drug resistance reversion in tumor cells by multidrug resistant gene antisense oligonucleotides. Chin J Hematol 1997;18(2): 76–79.

    Google Scholar 

  16. zhang FC, lin YM, jiang YZ, et al. Study on effect of antisense gene in reversing multidrug resistance of tumor cells and inducing cell apoptosis. Chin J Hematol 1997; 18(12): 627–629.

    CAS  Google Scholar 

  17. ZHANG WQ, LIU XY, LIU HY, et al. Multidrug resistance reversion of Chinese drug RI in adriamycin resistant human mammary cancer cell line MCF7 amp;dr. Pharmacol and Clin of Chin Meteria Medica 1994; (5) : 16–21.

  18. xu WL, ao ZF, chen YX, et al. Experimental study on effect of tetrandrine in enhancing therapeutic effect of rubidomycin and vincristine. Chin J Hematol 1994; 15(5): 256–257.

    Google Scholar 

  19. chen ZT, gu ZD. Effect of Chinese herbs on fluidity of cytomembrane in mice with lymphocytic leukemia. Chin J Integr Med (Chin) 1991;11(1): 39–40.

    CAS  Google Scholar 

  20. sun HD, li YS, ma L, et al. Thirty-two cases of APL treated with Ailing No. 1 and TCM treatment by Syndrome Differentiation. Chin J Integr Med (Chin) 1992;12(2): 170–171.

    Google Scholar 

  21. tang YJ, gu ZD. Effect of Liushen Pill on anti-relapse of acute leukemia. J TCM 1993; 34(2): 110.

    Google Scholar 

  22. qiu HY. Progress of study drug on resistance of APL to retinoic acid, the mechanism and measures against it. Foreign Med (fascicle of blood transfusion and hematol) 1999;22(1): 39–41.

    Google Scholar 

  23. huang SL. Clinical observation on treatment of APL mainly with composite indigo tablet. Chin J Hematol 1995;16(1): 26–28.

    Google Scholar 

  24. zhang P, wang SY, hu LH, et al. Seventy-two cases of APL treated with AS2O3 injection. Chin J Hematol 1996;17(2): 58–60.

    Google Scholar 

  25. hu XM, ma L, hu NP, et al. Treatment of 62 cases of acute promyelocytic leukemia by Ailing No. 1. Chin J Integr Med (Chin) 1999;19(8): 473–476.

    CAS  Google Scholar 

  26. wang SY, xiao YJ, yang HF, et al. Primary study on treatment of acute promyelocytic leukemia with arsenic preparation. Leukemia 1999; 8(6): 341–342.

    Google Scholar 

  27. li JH, zhao SJ, wang SQ, et al. Observation on effect of Ailing No. 1 in treating recurrent acute promyelocytic leukemia. Leukemia 1999; 8(6): 360–361.

    Google Scholar 

  28. chen GQ, zhu J, shi XG, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (AS2O3) in the treatment of acute promyelocytic leukemi- a:As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RARα/PML protein. Blood 1996;88: 1052–1061.

    PubMed  CAS  Google Scholar 

  29. tang W, chen GQ, shen ZX, et al. In vitro study on arsenic oxide inducing cell apoptosis in promyelocytic leukemia. Chin J Hematol 1997; 18(12): 623–626.

    CAS  Google Scholar 

  30. cai X, jia PM, shi XG, et al. In vitro study on arsenic oxide inducing cell apoptosis in retinoic resistance promyelocytic leukemia cells (MR-2). Chin J Hematol 1998; 19(7): 339–341.

    CAS  Google Scholar 

  31. huang XJ. Regulatory effect of apoptosis induction of AS2O3. Chin J Hematol 1999; 20(2): 258–260.

    CAS  Google Scholar 

  32. yang CZ. Progress of study on drug resistance of tumor and its counteracting. Chin J Hematol 1997 ; 18(2): 59–60.

    Google Scholar 

  33. wei HL. Multidrug resistance of tumor and the strategem against it. Foreign Med (fascicle of blood transfusion and hematol) 2000; 23(1): 28–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Xiyuan Hospital Affiliated to China Academy of TCM, National TCM Therapeutic Center of Hematopathy, 100091, Beijing

    Xiao-mei Hu, Cheng-shan Deng & Rou Ma

Authors
  1. Xiao-mei Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheng-shan Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rou Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-mei Hu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, Xm., Deng, Cs. & Ma, R. Present status of study on reversion of anti-leukemic multidrug resistance. CJIM 7, 307–311 (2001). https://doi.org/10.1007/BF02934384

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02934384

Keywords

Search

Navigation